• <kbd id="hmaqz"></kbd>
  • <blockquote id="hmaqz"><del id="hmaqz"><legend id="hmaqz"></legend></del></blockquote>
    Language:English|中文
    The Current Position:Home > News Center
    News Center
    Innovative Anti-HIV Drug ACC007 Received CFDA Approval for Clinical Trials
    2017-03-28 Source:江蘇艾迪藥業有限公司
           Clinical trial of ACC007, an innovative anti-HIV drug has been officially approved by China Food and Drug Administration (CFDA) on March 10th , 2017. ACC007 which is a kind of non-nucleoside reverse transcriptase inhibitors, is the second innovative drug in Aidea’s pipeline with intellectual property rights
     
     
    Jiangsu Aidea Pharmaceutical Co., Ltd
    Tel:0514-87530666
    Email:AD@www.sassysillyspunkymomma.com
    Address:No.2 Liuzhuang Road, Hanjiang District, Yangzhou
    版權歸 ? "Jiangsu Aidea Pharmaceutical Co., Ltd所有 蘇ICP備14046468號 Powered by vancheer
    2017夜夜干天天骑日日日